Impact of Novel Low-Density Lipoprotein-Cholesterol Assessment on the Utility of Secondary Non-High-Density Lipoprotein-C and Apolipoprotein B Targets in Selected Worldwide Dyslipidemia Guidelines-Reference-Cited by-同舟云学术

Impact of Novel Low-Density Lipoprotein-Cholesterol Assessment on the Utility of Secondary Non-High-Density Lipoprotein-C and Apolipoprotein B Targets in Selected Worldwide Dyslipidemia Guidelines

Published:2018-07-17 Issue:3 Volume:138 Page:244-254
ISSN:0009-7322
Container-title:Circulation
language:en
Short-container-title:Circulation

Author:

Sathiyakumar Vasanth¹,Park Jihwan²,Quispe Renato¹,Elshazly Mohamed B.³,Michos Erin D.¹,Banach Maciej⁴,Toth Peter P.¹⁵⁶,Whelton Seamus P.¹,Blumenthal Roger S.¹,Jones Steven R.¹,Martin Seth S.¹⁷

Affiliation:

1. Johns Hopkins Ciccarone Center for the Prevention of Cardiovascular Disease, Baltimore, MD (V.S., R.Q., E.D.M., P.P.T., S.P.W., R.S.B., S.R.J., S.S.M.).

2. Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD (J.P.).

3. Department of Medicine, Division of Cardiology, Weill Cornell Medical College-Qatar, Education City, Doha, Qatar (M.B.E.).

4. Department of Hypertension, Division of Nephrology and Hypertension, Medical University of Lodz, Poland (M.B.).

5. Department of Preventive Cardiology, CGH Medical Center, Sterling, IL (P.P.T.).

6. College of Medicine, University of Illinois, Peoria, IL (P.P.T.).

7. Welch Center, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD (S.S.M.).

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Physiology (medical),Cardiology and Cardiovascular Medicine

Reference41 articles.

1. Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) Final Report

2. National Lipid Association Recommendations for Patient-Centered Management of Dyslipidemia: Part 1—Full Report

3. 2013 ACC/AHA Guideline on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in Adults

4. 2016 ESC/EAS Guidelines for the Management of Dyslipidaemias

5. 2016 Canadian Cardiovascular Society Guidelines for the Management of Dyslipidemia for the Prevention of Cardiovascular Disease in the Adult

Cited by 36 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Traditional and Novel Markers: Target of Treatment vs Marker of Risk;Canadian Journal of Cardiology;2024-08

2. Apolipoprotein B: Bridging the Gap Between Evidence and Clinical Practice;Circulation;2024-07-02

3. Measurement of Low-Density Lipoprotein Cholesterol, Non–High-Density Lipoprotein Cholesterol, Apolipoprotein B, and Low-Density Lipoprotein Particle Concentration;Clinical Lipidology;2024

4. American Association of Clinical Endocrinology Consensus Statement: Comprehensive Type 2 Diabetes Management Algorithm – 2023 Update;Endocrine Practice;2023-05

5. Validation of low-density lipoprotein cholesterol equations in pediatric population;PeerJ;2023-01-05